160 related articles for article (PubMed ID: 9380768)
21. The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model.
Kroeger RJ; Groszmann RJ
Hepatology; 1985; 5(3):425-30. PubMed ID: 3922868
[TBL] [Abstract][Full Text] [Related]
22. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
[TBL] [Abstract][Full Text] [Related]
23. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
[TBL] [Abstract][Full Text] [Related]
24. Nipradilol, a new beta-blocker with vasodilatory properties, in experimental portal hypertension: a comparative haemodynamic study with propranolol.
Um S; Nishida O; Tokubayashi M; Kimura F; Kita T
J Gastroenterol Hepatol; 1993; 8(5):414-9. PubMed ID: 8105997
[TBL] [Abstract][Full Text] [Related]
25. Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Reboredo M; Chang HC; Barbero R; Rodríguez-Ortigosa CM; Pérez-Vizcaíno F; Morán A; García M; Banales JM; Carreño N; Alegre F; Herrero I; Quiroga J; Prieto J; Sangro B
PLoS One; 2013; 8(1):e52683. PubMed ID: 23341903
[TBL] [Abstract][Full Text] [Related]
26. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients.
Vorobioff J; Picabea E; Villavicencio R; Puccini V; Rossi O; Bordato J; Audano M
Hepatology; 1987; 7(4):648-53. PubMed ID: 3610045
[TBL] [Abstract][Full Text] [Related]
27. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
28. Effects of tetrandrine on left ventricle hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Xu Y; Rao MR
Eur J Pharmacol; 1995 May; 278(1):1-7. PubMed ID: 7664810
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic effects of synephrine treatment in portal hypertensive rats.
Huang YT; Lin HC; Chang YY; Yang YY; Lee SD; Hong CY
Jpn J Pharmacol; 2001 Feb; 85(2):183-8. PubMed ID: 11286401
[TBL] [Abstract][Full Text] [Related]
30. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats.
Calès P; Braillon A; Girod C; Lebrec D
J Hepatol; 1985; 1(4):349-57. PubMed ID: 4056347
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular hyporesponsiveness to norepinephrine, propranolol and nitroglycerin in portal-hypertensive and aged rats.
Polio J; Sieber CC; Lerner E; Groszmann RJ
Hepatology; 1993 Jul; 18(1):128-36. PubMed ID: 8325604
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive hemodynamic measurements of superior mesenteric artery in the prediction of portal pressure response to propranolol.
Iwao T; Oho K; Sakai T; Sato M; Nakano R; Yamayaki M; Toyonaga A; Tanikawa K
J Hepatol; 1998 May; 28(5):847-55. PubMed ID: 9625321
[TBL] [Abstract][Full Text] [Related]
33. Comparative portal hypotensive effects as propranolol of vitamin D₃ treatment by decreasing intrahepatic resistance in cirrhotic rats.
Lee PC; Yang YY; Lee WP; Lee KC; Hsieh YC; Lee TY; Lin HC
J Gastroenterol Hepatol; 2015 Mar; 30(3):628-37. PubMed ID: 25187428
[TBL] [Abstract][Full Text] [Related]
34. Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol.
Moreau R; Cailmail S; Gadano A; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Aug; 11(4):775-9. PubMed ID: 9305488
[TBL] [Abstract][Full Text] [Related]
35. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
Kroeger RJ; Groszmann RJ
Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
[TBL] [Abstract][Full Text] [Related]
36. [Effects of tetrandrine on cardiac hemodynamics of hypertrophied left ventricle from deoxycorticosterone-salt hypertensive rats].
Xu Y; Rao MR
Yao Xue Xue Bao; 1995; 30(2):86-92. PubMed ID: 7785436
[TBL] [Abstract][Full Text] [Related]
37. Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats.
Hillon P; Blanchet L; Lebrec D
Clin Sci (Lond); 1982 Jul; 63(1):29-32. PubMed ID: 7083761
[TBL] [Abstract][Full Text] [Related]
38. Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats.
Huang YT; Lin HC; Tsai JF; Hou MC; Lee SD; Hong CY
J Hepatol; 1998 Jun; 28(6):1037-44. PubMed ID: 9672181
[TBL] [Abstract][Full Text] [Related]
39. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
[TBL] [Abstract][Full Text] [Related]
40. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats.
Lee SS; Sharkey KA
Am J Physiol; 1993 May; 264(5 Pt 1):G868-73. PubMed ID: 8498513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
